Deep Tech Startups

Allvision develops solutions to make 3D spatial data useful and accessible, using LiDAR, computer vision, and machine learning for reality capture and autonomous systems. The company applies its technology across geospatial data and autonomous systems applications.

1 investor

Almawave develops artificial intelligence technologies including natural language processing, generative AI, symbolic AI, conversational AI, speech technology, and machine learning. It provides AI-based products and solutions for processing language and data.

1 investor

The page presents a company operating in the Industrial Internet of Things (IIoT) domain, with a regional presence for customers.

1 investor

Alp Bio operates a platform that combines human tonsil organoid technology with protein AI models to assess and reduce immunogenicity (anti-drug antibody) risk in therapeutic antibodies before clinical development. It serves biologics developers with in-silico ADA screening, ex vivo tonsil organoid assays, and generative redesign of antibody sequences.

1 investor

Alpha Ring develops micro-fusion systems, including a tabletop fusion education device (Alpha-E), an aneutronic proton-boron fusion energy reactor (Alpha-F), and a medical ion beam system for Boron Neutron Capture Therapy (Alpha-M). It targets research institutions, industrial energy applications, and healthcare in the clean energy and nuclear fusion sector.

1 investor

AQT builds trapped-ion quantum computers in a 19-inch rack format that operate at room temperature and consume under 2kW, designed for integration into HPC data centres and accessible via the cloud. The systems target computing challenges in fields such as finance, chemistry, and logistics.

1 investor

Alpine Optoelectronics designs and manufactures high-speed optical transceivers, including 100G QSFP28 DWDM/xWDM and 800G QSFP-DD/OSFP LPO modules built on silicon photonics for data center and networking links over single-mode fiber. Its products target network equipment and data center operators needing multi-terabit optical interconnects.

1 investor

Alpine Space is a venture capital firm that invests in early-stage startups in the space and space-enabled industries, backing teams building scalable technologies with commercial potential in existing markets.

1 investor

Alqem uses AI combined with domain expertise in chemistry and physics to discover new crystalline materials, aiming to identify breakthrough materials validated in the real world. The company operates in materials discovery for the chemical and energy industries.

1 investor

AlSentis develops touch technology, offering no-tuning touch input systems, software, and products for organizations that require precise and reliable performance, including in challenging environments. Its solutions are aimed at teams building touch-based products with demanding durability and ergonomic requirements.

1 investor

Atlas AI provides outsourced R&D services combining wet-lab execution, bioinformatics, and AI modeling, including proteomics, cell culture, and protein/enzyme engineering for industrial and environmental applications. It serves biotech and industrial R&D teams that want to accelerate projects without building their own labs or internal teams, delivering data, models, and deployable software platforms.

1 investor

ALTDATA builds physics-anchored AI digital twins for biomedical research, letting scientists simulate thousands of experimental permutations with a confidence score on each result before running physical experiments. Its models are constrained to avoid biologically impossible outputs and can simulate how gravity affects 3-D cell cultures.

1 investor

Altered Carbon builds a chemical-sensing platform based on proprietary graphene nanomaterials that lets machines detect and interpret airborne chemical signals at ultra-low power. The technology serves applications across the built environment, healthcare, food and agriculture, security and defence, industrial infrastructure, and robotics/autonomous systems.

1 investor

AlterEgo builds a non-invasive, wearable neural interface that uses "Silent Sense" technology to let users communicate with AI through silent, intentional speech without typing, tapping, or speaking aloud. Developed at MIT, the device targets hands-free, screen-free human-computer interaction.

1 investor

ABio-X is an incubation platform that creates life sciences companies by combining new technologies with scientific research to develop drug candidates for large, historically difficult diseases. It supports member companies in advancing assets into research and development candidates aimed at commercialization for patients globally.

1 investor

Altitud 100K is a Chilean applied-science company offering AI, automation, engineering, and STEM training services, along with R&D in oncology, medical engineering, and aerospace engineering (CubeSats). It serves businesses seeking AI adoption and process automation, schools and universities wanting STEM programs, and health and research institutions.

1 investor

Altratech has developed a multianalyte molecular diagnostic platform that simultaneously detects and quantifies DNA, RNA, antibodies, and antigens, combining serology and nucleic acid detection in one system. The technology is aimed at point-of-care molecular diagnostics.

1 investor

Altris develops sodium-ion battery cells built on conflict-free minerals as an alternative to lithium and lead-acid batteries. Its cells target automotive low-voltage, data centers, grid and residential storage, and defence applications, with a focus on European supply chains.

1 investor

Alva Health develops wearable medical devices that continuously monitor for early signs of stroke and alert emergency responders in real time. The company serves patients at risk of stroke and the healthcare system, focusing on improving outcomes through rapid detection and treatment initiation.

1 investor

Alva develops solutions for delivering new nuclear power generation capacity on time and on budget, serving utilities and energy operators building utility-scale nuclear systems.

1 investor

Alyssum Therapeutics is a clinical-stage biotech developing small-molecule immunotherapies that modulate B cells to treat solid cancers and other complex diseases. Its lead molecule, AT-1965, inhibits the novel target CMTR2 and recruits a B cell immune response, and the company uses a patented quantum mechanics platform to optimize drug efficacy and safety.

1 investor

Amaryllis Tx develops tissue-targeted drug delivery by mapping tissue-specific glycan signatures and designing peptides that recognize them, using in silico and in vivo screening. Its lead peptide enables subcutaneously injected payloads such as antibodies, mRNA, ASO, and siRNA to cross the blood-brain barrier, initially targeting the brain.

1 investor

AMATAMA develops technology platforms and services for humanoid robotics, combining computing, mechanics, design, and hierarchical computing middleware. The company engages in robot manufacturing and R&D for the robotics industry.

1 investor

AMB AI builds an AI-powered platform that fuses continuous multi-sensor data into dynamic 3D digital twins of tunnels, sewers, and other critical assets, offering monitoring and predictive risk analytics. It serves operators of high-value infrastructure including mining assets, civil infrastructure, and subsurface systems.

1 investor